Company Search:
Advanced Search
Sponsored Links
Neurocrine Biosciences Inc Company Snapshot
Neurocrine Biosciences Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Neurocrine Biosciences Inc with three other companies in this sector in the United States: ALK-Abello A/S (2018 sales of $460.77 million of which 61% was SCIT/SLIT drops), Acorda Therapeutics, Inc. ($471.43 million of which 98% was Net product revenues), and BIO-TECHNE Corp ($642.99 million of which 66% was Biotechnology).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Neurocrine Biosciences Inc
  Stock Performance Chart for Neurocrine Biosciences Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 90.33
(Figures in U.S. Dollars)
1 Week 0.7%   13 Weeks -6.3%  
4 Weeks 5.4%   52 Weeks -19.0%  
Neurocrine Biosciences Inc Key Data:
  Ticker: NBIX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 451,240,000
(Year Ending Jan 2019).
Employees: 585
  Currency: U.S. Dollars Market Cap: 8,272,367,292
  Fiscal Yr Ends: December Shares Outstanding: 91,579,401
  Share Type: Common Closely Held Shares: 1,159,004
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.